Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial.
Publication
, Journal Article
Mejias, J; Gonzalez-Barreto, AR; Rodeghier, M; DeBaun, MR
Published in: Blood advances
November 2024
Duke Scholars
Published In
Blood advances
DOI
EISSN
2473-9537
ISSN
2473-9529
Publication Date
November 2024
Volume
8
Issue
22
Start / End Page
5853 / 5854
Related Subject Headings
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Mejias, J., Gonzalez-Barreto, A. R., Rodeghier, M., & DeBaun, M. R. (2024). Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial. Blood Advances, 8(22), 5853–5854. https://doi.org/10.1182/bloodadvances.2024013216
Mejias, Jose, Alejandro R. Gonzalez-Barreto, Mark Rodeghier, and Michael R. DeBaun. “Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial.” Blood Advances 8, no. 22 (November 2024): 5853–54. https://doi.org/10.1182/bloodadvances.2024013216.
Mejias J, Gonzalez-Barreto AR, Rodeghier M, DeBaun MR. Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial. Blood advances. 2024 Nov;8(22):5853–4.
Mejias, Jose, et al. “Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial.” Blood Advances, vol. 8, no. 22, Nov. 2024, pp. 5853–54. Epmc, doi:10.1182/bloodadvances.2024013216.
Mejias J, Gonzalez-Barreto AR, Rodeghier M, DeBaun MR. Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial. Blood advances. 2024 Nov;8(22):5853–5854.
Published In
Blood advances
DOI
EISSN
2473-9537
ISSN
2473-9529
Publication Date
November 2024
Volume
8
Issue
22
Start / End Page
5853 / 5854
Related Subject Headings
- 3201 Cardiovascular medicine and haematology